Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

Breakdown of ‘protective mechanisms’ can drive lung cancer development

Breakdown of ‘protective mechanisms’ can drive lung cancer development

Researchers identify new biomarkers of the most frequent lung cancer

Researchers identify new biomarkers of the most frequent lung cancer

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in whom they are currently used

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in...

Food-drug interactions could be impactful for some lung cancer patients

Food-drug interactions could be impactful for some lung cancer patients

Food-drug interactions could be key for some lung cancer patients

Food-drug interactions could be key for some lung cancer patients

ASCO 2023: Personalised vaccines may revolutionise cancer treatment

ASCO 2023: Personalised vaccines may revolutionise cancer treatment

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

ASCO 2023: Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced...

ASCO 2023: Osimertinib after surgery significantly improves survival in patients with resected EGFR-mutated non-small cell lung cancer

ASCO 2023: Osimertinib after surgery significantly improves survival in patients with resected EGFR-mutated non...

More from ecancer